Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Merck KGaA
Merck KGaA
Better Together – Merck KGaA Announces Collaboration with Artios
Better Together – Merck KGaA Announces Collaboration with Artios
BioSpace
Merck KGaA
Artios Pharma
drug development
cancer
oncology
Flag link:
Merck KGaA Diversifies with First Female CEO
Merck KGaA Diversifies with First Female CEO
BioSpace
Merck KGaA
Female Executives
Pharma CEOs
Belén Garijo
Flag link:
ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial
ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial
Fierce Pharma
ESMO
Pfizer
Merck KGaA
Bavencio
head and neck cancer
clinical trials
Flag link:
Merck KGaA : to Invest EUR59 Million to Expand Pharmaceutical Manufacturing at US Facility
Merck KGaA : to Invest EUR59 Million to Expand Pharmaceutical Manufacturing at US Facility
Market Screener
drug manufacturing
Merck KGaA
Flag link:
Big pharma spinouts grow up
Big pharma spinouts grow up
EP Vantage
Big Pharma
spinoffs
Merck KGaA
Pfizer
GSK
Novartis
Roche
Sanofi
JNJ
AstraZeneca
Flag link:
FDA starts quick review of Merck KGaA’s MET-targeting lung cancer drug
FDA starts quick review of Merck KGaA’s MET-targeting lung cancer drug
Pharmaforum
Merck KGaA
MET inhibitors
tepotinib
lung cancer
Flag link:
Merck KGaA picks up another anticancer bispecific from F-star
Merck KGaA picks up another anticancer bispecific from F-star
Fierce Biotech
Merck KGaA
F-star Therapeutics
immuno-oncology
bispecific antibodies
Flag link:
Merck KGaA's manufacturing group could see billions from COVID-19 work: analyst
Merck KGaA's manufacturing group could see billions from COVID-19 work: analyst
Fierce Pharma
COVID-19
vaccines
drug manufacturing
Merck KGaA
Flag link:
Merck KGaA’s ATR cancer drug cleared for further trials after phase 1 trial success
Merck KGaA’s ATR cancer drug cleared for further trials after phase 1 trial success
Pharmaforum
Merck KGaA
cancer
clinical trials
DNA repair
Flag link:
Marketing In another round of Merck vs. Merck, Germany-based Merck KGaA notches a win in the U.K.
Marketing In another round of Merck vs. Merck, Germany-based Merck KGaA notches a win in the U.K.
Fierce Pharma
Merck
Merck KGaA
trademark
Flag link:
ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer
ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer
Fierce Pharma
Pfizer
Merck KGaA
Bavencio
ASCO 2020
bladder cancer
gestational trophoblastic tumors
clinical trials
Flag link:
Newron's Merck KGaA-in licensed compound fails Rett Syndrome study, shares wilt
Newron's Merck KGaA-in licensed compound fails Rett Syndrome study, shares wilt
Endpoints
Newron Pharma
Merck KGaA
Rett Syndrome
sarizotan
clinical trials
Flag link:
German Merck to spend $110M on new gene therapy facility in California
German Merck to spend $110M on new gene therapy facility in California
BioPharma Dive
Merck KGaA
gene therapy
California
drug manufacturing
Flag link:
Merck KGaA amps up in gene therapy with $110M viral vector manufacturing boost
Merck KGaA amps up in gene therapy with $110M viral vector manufacturing boost
Fierce Pharma
Merck KGaA
MilliporeSigma
gene therapy
drug manufacturing
Flag link:
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
Flag link:
In two-man race with Novartis, Merck scores first regulatory approval for targeted lung cancer drug
In two-man race with Novartis, Merck scores first regulatory approval for targeted lung cancer drug
Endpoints
Novartis
Merck KGaA
Japan
tepotinib
non-small cell lung cancer
Flag link:
Merck KGaA donates multiple sclerosis med Rebif to French COVID-19 trial
Merck KGaA donates multiple sclerosis med Rebif to French COVID-19 trial
Fierce Pharma
Merck KGaA
COVID-19
Rebif
clinical trials
Flag link:
Bavencio from Merck KGaA, Pfizer encounters yet another trial setback
Bavencio from Merck KGaA, Pfizer encounters yet another trial setback
Endpoints
Merck KGaA
Pfizer
Bavencio
clinical trials
head and neck cancer
Flag link:
Merck KGaA partners with tech firm AMCM on tablet 3D printing
Merck KGaA partners with tech firm AMCM on tablet 3D printing
Pharmaforum
Merck KGaA
AMCM
3D printing
CMDO
drug manufacturing
Flag link:
To challenge Ocrevus, German Merck takes on Aubagio
To challenge Ocrevus, German Merck takes on Aubagio
EP Vantage
Ocrevus
Merck KGaA
Aubagio
evobrutinib
MS
multiple sclerosis
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »